ATLANTA - UCB, Inc., a leading biopharmaceutical company dedicated to the research and development of treatments for severe central nervous system and immunological disordersis marking Digestive Disease Week (DDW) 2012 in San Diego by reinforcing its commitment to improving the lives of patients w More …

LOS ANGELES - At the 2nd Annual Symposium for Lung-Sparing Therapies for Malignant Pleural Mesothelioma held this weekend at the Sheraton Delfina in Santa Monica, CAinternational experts again re-affirmed the general consensus that radical operations which remove a patient's lung, such as extraple More …

Pfizer Inc.’s Xalkori, a drug that targets lung cancer caused by a gene defect, wiped out all signs of malignancy in some children with different tumor types, in a study that proves aiming treatment at genes rather than disease sites may be more effectiveThe findings, being released today in adv More …